AI in Health Data Consent Management Market Size, Share & Industry Analysis, By Component (Software/Platforms and Services), By Consent Type (Patient Consent Management, Research/Data-Sharing Consent, and Dynamic Consent Management), By Technology (NLP, Machine Learning & Deep Learning, and Generative AI/LLMs), By Data Type (Clinical/EHR Data, Genomic Data, and Clinical Trial Data), By Application (Consent Capture & Verification, Preference Management, and Policy Automation), By End User (Hospitals & Health Systems, Life Sciences Companies, and Payers), and Regional Forecast, 2026-2034

The global AI in health data consent management market was valued at USD 0.45 billion in 2025. The market is projected to grow from USD 0.57 billion in 2026 to USD 3.80 billion by 2034, exhibiting a CAGR of 26.8% during the forecast period.

The global market is emerging as a significant area within healthcare data governance. Large volumes of sensitive patient data are generated across hospitals, life sciences companies, payers, and research networks. As data-sharing activities increase, organizations need stronger systems to capture patient consent, manage data-use preferences, track consent withdrawal, and maintain audit-ready compliance records. AI-enabled consent management platforms help automate consent classification, document interpretation, policy mapping, and compliance monitoring, among other applications. This is encouraging healthcare organizations to adopt digital and dynamic consent solutions that support patient trust, regulatory compliance, and responsible use of data across the healthcare ecosystem.

• For instance, in June 2025, MD Anderson Cancer Center collaborated with HealthEx to develop an AI-powered patient data consent platform that gives patients direct control over how their health data is accessed and used. The platform is designed to help healthcare organizations create, curate, and enforce patient consent and data-access preferences, while supporting automated workflows for compliance. These developments support the market growth and help improve transparency, trust, and responsible health data sharing.

Furthermore, funding initiatives, technological advancements, strategic collaborations, and new product launches by key operating companies strengthen their market position and support global market growth.

AI in Health Data Consent Management Market Driver

Growing Use of AI and Real-World Data in Healthcare to Increase Demand for Consent Governance Platforms

Large volumes of data are being used for AI model training, clinical research, real-world evidence studies, population health, payer analytics, and product development. As the number of data users increases, it becomes difficult to manually track whether a patient has allowed their data to be used, for what purpose is permitted, whether consent has expired, and whether the patient has withdrawn permission. AI-enabled consent governance platforms solve this problem by linking patient permissions directly with data access, data sharing, and audit workflows as this data moves across hospitals, life sciences companies, payers, research networks, and technology partners, organizations need a clear way to understand whether the data can be accessed, shared, analyzed, or reused for specific purposes. This creates strong demand for consent governance platforms that can capture patient permissions, classify consent terms, manage opt-ins and opt-outs, and maintain audit trails across multiple data systems. AI further strengthens this demand as it can automate consent interpretation, identify gaps in consent coverage, and help enforce patient preferences at scale. As a result, organizations are adopting AI-enabled consent platforms to reduce compliance risk, improve patient trust, and support responsible use of health data for AI and real-world evidence programs. Key companies are increasingly focusing on redirecting their resources toward new product launches to strengthen their market presence.

• For instance, in May 2025, Velatura Public Benefit Corporation, in collaboration with Trusted Data Sharing Organizations (TDSO), launched Consent Manager+, an AI-driven solution designed to transform how patient consent is captured, managed, and honored.

Download Free sample to learn more about this report.

In July 2025, a study published in BMC Health Services Research analyzed 27 studies evaluating technologies used to digitalize informed consent processes. AI-based technologies accounted for 30% of the included studies, representing the most frequently identified technology category and highlighting the increasing role of AI in supporting digital consent workflows.

AI in Health Data Consent Management Market Restraint

Fragmented Data Privacy Regulations across Regions to Create Implementation Challenges

The lack of uniform data privacy rules across countries and regions restrains the growth of the global market. Healthcare organizations that operate across multiple markets must comply with different consent requirements under regulations such as HIPAA in the U.S., GDPR in Europe, and other national privacy laws in other parts of the world. These factors create complexity as one consent workflow may not be valid for every geography, data type, or use case. As a result, vendors and healthcare organizations need to customize consent capture, withdrawal, data-sharing rules, retention policies, and audit documentation for each regulatory environment. This increases implementation time, raises compliance costs, and slows adoption, especially for smaller providers and research organizations with limited legal and IT resources. T

• For instance, in July 2025, Ours Privacy launched an end-to-end privacy solution for healthcare marketing, stating that healthcare organizations were facing “exploding complexity” from HIPAA requirements and a wave of new and changing U.S. state privacy laws. Such inconsistent governance across healthcare partners can create major legal and trust risks.

AI in Health Data Consent Management Market Opportunity

Rising Use of Health Data for AI Model Training to Create Demand for Consent Governance Platforms

The global market is expected to witness strong growth opportunities over the upcoming years as hospitals are increasingly using patient data to train, test, and improve AI models. AI development requires large and diverse datasets such as EHRs, imaging records, claims data, genomics, lab results, and patient-generated data. However, this data cannot be used freely as patients, regulators, and healthcare institutions are becoming more cautious about how sensitive health information is shared and reused. This creates a strong need for consent governance platforms that can clearly define whether patient data can be used for research, AI training, commercial analytics, or secondary data use. AI-enabled consent tools can also help classify consent language, identify missing permissions, manage withdrawal requests, and create audit-ready records. As a result, the rising use of health data for AI model training is opening a major opportunity for platforms that can make data use more transparent, compliant, and trusted.

• For instance, in July 2025, Relyance Inc introduced its first AI-native Consent Management platform to meet the urgent demands of the modern digital landscape. The platform leverages powerful AI to discover and classify all tracking technologies automatically, blocks unapproved trackers before they load, and continuously enforces consent across your data ecosystem.

Segmentation

Key Insights

The report covers the following key insights:

• Overview of Technological Advancements in AI-enabled Consent Management
• Overview of Integration and Interoperability Landscape
• Regulatory Scenario, By Key Countries/Regions
• New Product Launches, By Key Players
• Key Industry Developments (Strategic Partnerships, Acquisitions, and Mergers)
• Key Startups, By Key Regions

Analysis by Component

Based on component, the global AI in health data consent management market is segmented into software/ platforms and services.

The software/platforms segment is anticipated to dominate the global market. Healthcare organizations are moving toward centralized digital systems that can manage consent across EHRs, clinical trials, data exchanges, and analytics workflows. As patient data becomes more widely used for care coordination, research, and AI model development, organizations need scalable platforms that can capture consent, store permissions, manage withdrawals, automate audit trails, and connect with downstream data systems. This creates stronger demand for software platforms than standalone services as platforms provide repeatable, automated, and enterprise-wide consent governance. Underscoring the importance of software solutions in the market, key companies are actively launching innovative products to cater to the needs of the market. 

• For instance, in June 2025, OneTrust launched OneTrust Consent Management as a Snowflake Native App on Snowflake Marketplace. The launch was designed to help organizations activate trusted customer data by connecting consent and preference data directly into Snowflake environments. Such instances support the growth of the segment as they highlight how consent management is being embedded into enterprise data platforms to automate compliant data use at scale.

Analysis by Consent Type

Based on consent type, the market is segmented into patient consent management, research/data-sharing consent, dynamic consent & preference management, and others.

The patient consent management segment captures the largest share in the market. Patient consent is the most common and commercially established use case across hospitals and outpatient clinics, which is driving segment growth. As healthcare becomes more digital, patient consent must be connected to EHR workflows, patient portals, health information exchanges, and data-sharing policies. This makes patient consent management the largest segment. New product launches and strategic collaborations among key players further cement its dominance.

• For instance, in December 2024, Bumrungrad International Hospital collaborated with Certinal eSign to drive efficiency, enhance security, and redefine the patient experience through advanced eSignatures and digitized workflows. Such instances support the dominance of patient consent management.

Analysis by Technology

Based on technology, the AI in health data consent management market is segmented into natural language processing (NLP), machine learning & deep learning, generative AI / large language models (LLMs), computer vision / OCR-based document intelligence, and others.

The Natural Language Processing (NLP) segment holds the largest market share. Healthcare consent information is mostly stored in text-heavy formats such as informed consent forms, privacy notices, patient authorization documents, research protocols, data-use agreements, scanned records, and policy documents. Organizations need AI tools that can read, extract, classify, and interpret this language to understand what a patient has agreed to, what data can be shared, and what restrictions must be applied. The technology helps convert unstructured consent language into structured rules that EHRs, trial systems, analytics platforms, and compliance teams can use.

• For instance, in October 2025, Medidata announced notable advances to Medidata Consent, its electronic informed consent technology, including an AI-assisted setup to accelerate study build and reduce manual work. The modernized solution focuses on adaptability, usability, and global compliance to remove adoption barriers and improve patient recruitment from the first interaction.

Analysis by Data Type

Based on data type, the market is segmented into clinical/EHR Data, genomic & omics data, clinical trial & research data, patient-generated health data, claims & insurance data, and others.

The clinical/EHR data segment dominates the market as EHRs remain the primary source of patient information used across care delivery, referrals, health information exchanges, payer reviews, research screening, quality reporting, and AI-enabled analytics. Since EHR data contains sensitive diagnoses, medications, lab results, procedures, imaging references, and physician notes, organizations must clearly manage who can access the data and for what purpose. This creates strong demand for consent tools that can operate close to clinical systems and apply consent rules to everyday data-sharing activities. Genomic, omics, trial, wearable, and claims data are important growth areas. Still, clinical/EHR data dominates as it has the widest usage frequency, the largest institutional footprint, and the most direct connection to patient care workflows.

• For instance, in March 2025, Datavant launched its enhanced Clinical Insights Platform to help health plans and risk-bearing providers identify, access, analyze, and act on clinical data. The platform is an integrated offering created through its integration with Apixio. The platform supports the dominance of clinical/EHR data.

Analysis by Application

Based on application, the market is segmented into consent capture & verification, consent classification and tagging, data-sharing preference management, audit trail, policy automation & compliance monitoring, and others.

The consent capture & verification segment dominates the AI in health data consent management market. It is one of the most essential steps in any consent management workflow. Before organizations can classify consent, manage preferences, automate policies, or monitor compliance, they must first capture a valid consent decision and verify that it is complete, current, traceable, and linked to the right patient or participant record. This makes capture and verification the largest application area across hospitals, clinical trials, payers, and research networks. AI improves this segment by checking form completeness, matching consent to identity, flagging missing signatures, supporting remote consent, and reducing manual verification errors.

• For instance, in February 2026, DATATRAK announced its Standalone eConsent solution to accelerate clinical trials by integrating consent data and enrollment status with subject records, randomization, and visit schedules when used with DATATRAK EDC. The solution supports remote and decentralized clinical trials and can integrate with third-party clinical trial systems or EDC platforms.

Analysis by End User

Based on end user, the market is segmented into hospitals & health systems, life sciences companies, payers, research institutes/data networks, and others.

The hospitals & health systems segment generates the largest volume of consent-linked health data through patient registration, treatment authorization, EHR access, referrals, diagnostics, research participation, and data-sharing with external partners. They also face the strongest operational pressure as consent must be managed across many departments, locations, systems, and care teams. These factors encourage them to invest in digital consent tools that reduce paperwork, improve audit readiness, support patient access, and enable compliant data exchange, leading to the dominance of the segment.

• For instance, in August 2025, Oracle announced its new AI-driven electronic health record, available for ambulatory providers in the U.S., as part of its effort to modernize EHR workflows. Oracle Health also offered Patient Electronic Signature capabilities for consent, registration, and privacy forms integrated with its EHR. This shows that major healthcare technology providers are embedding digital documentation, consent, and AI-enabled workflow modernization directly into provider-facing clinical systems.

Regional Analysis

Request for Customization   to gain extensive market insights.

The market, on the basis of region, has been analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for approximately 55.0% of the global AI in health data consent management market in 2025. The regional market is growing as the region has a mature digital health ecosystem, high EHR penetration, strong clinical research activity, and increasing use of patient data for AI, real-world evidence, and value-based care programs. This creates strong demand for AI-enabled consent platforms that can connect consent decisions with health data exchange workflows. Additionally, the U.S. focus on patient-directed data access and interoperability encourages key players to build consent-aware systems that allow patients to control how their health records are retrieved, shared, and reused. The region also witnesses numerous product launches and partnerships aiming to drive segment growth.

• For instance, in August 2025, HealthEx launched a platform to enable patients to access, retrieve, and share health records in real time through Individual Access Services under the TEFCA framework. The platform included patient outreach, identity verification, consent for data access, and clinical record retrieval and delivery. These factors collectively support North America’s growth and support secure interoperability and responsible data sharing.

The Europe market is expected to grow at a significant CAGR during the forecast period. The European market is growing as healthcare organizations and life sciences companies must operate under strict privacy, clinical research, and cross-border data protection requirements. Further, the region has strong clinical trial activity, increasing digital health adoption, and growing interest in decentralized and hybrid trial models. This creates demand for eConsent and AI-enabled consent management tools that can support multiple languages, country-specific requirements, patient comprehension, and compliant data-sharing across research sites. As a result, vendors with validated consent platforms and regulatory-ready workflows are gaining opportunities across European clinical research and healthcare data ecosystems.

• For instance, in March 2025, Medable announced that its eConsent and eCOA solutions received approval from France’s CNIL for use in clinical studies across the European Union. The approval expanded access for digital clinical trials across Europe and supported compliant use of patient-facing digital trial technologies. Such development supports Europe market growth.

Asia Pacific is expected to grow at a stable CAGR during the forecast period. The Asia Pacific region is witnessing growth as healthcare organizations across the region are rapidly digitizing patient intake, clinical trial participation, telehealth, and healthcare data workflows. As clinical trials and real-world data programs expand across the Asia Pacific, organizations need consent platforms that can support remote participation, multilingual workflows, identity verification, and secure data exchange. This creates a strong opportunity for AI-enabled consent management given that these tools help standardize consent capture and improve trust in data-sharing across diverse healthcare systems.

• For instance, in October 2025, Suvoda launched a unified patient app after its merger with Greenphire, bringing IRT, eCOA, eConsent, payments, travel, and budgeting capabilities together on the Suvoda Platform. The application was designed to reduce logistical challenges for clinical trial participants and support a more integrated patient journey.

Key Players Covered

The global AI in health data consent management market is moderately fragmented but increasingly consolidating.

The report includes the profiles of the following key players.

• OneTrust (U.S.)
• Veeva Systems Inc. (U.S.)
• Medidata (U.S.)
• HealthVerity, Inc. (U.S.)
• Datavant (U.S.)
• Veeam Software (U.S.)
• BigID, Inc. (U.S.)
• Microsoft Corporation (U.S.)
• Oracle Health (U.S.)
• InterSystems Corporation (U.S.)

Key Industry Developments

• January 2026: Usercentrics, a privacy-led marketing solutions provider, acquired MCP Manager, a next-generation governance platform for the Model Context Protocol (MCP), built by a team with deep expertise in AI infrastructure.
• December 2025: Veeam Software, a leader by market share in Data Resilience, completed its USD 1.73 billion acquisition of Securiti AI, the recognized leader in Data Security Posture Management (DSPM), privacy, governance, and AI trust.